Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Recludix Inks $1.3B Deal with Sanofi.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • المؤلفون: CLEMETSON, JEFF
  • المصدر:
    San Diego Business Journal. 7/31/2023, Vol. 44 Issue 31, p1-22. 2p.
  • معلومة اضافية
    • الموضوع:
      SANOFI SA; RESPIRATORY diseases; STAT proteins; SMALL molecules; ALLERGIES
    • نبذة مختصرة :
      The article aims on Recludix Pharma collaborates with Sanofi to develop oral STAT6 inhibitors for immune and inflammatory diseases. Their innovative platform targeting SH2 domains gains attention and investment, offering potential treatments for various ailments, including dermatological conditions, respiratory diseases, psoriasis, Crohn's Disease, rheumatoid arthritis, multiple sclerosis and cancer.